Non-Small Cell Lung Cancer (Stage III) Clinical Trials in Madrid, Madrid
2 recruitingMadrid, Madrid, Spain
Showing 1–2 of 2 trials
Recruiting
Phase 2
Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Non-Small Cell Lung Cancer (Stage III)KRAS P.G12C
Fundación GECP19 enrolled20 locationsNCT05398094
Recruiting
Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients
PDL1 Gene MutationNon-Small Cell Lung Cancer (Stage III)
Fundación GECP50 enrolled22 locationsNCT06634199